Hemophilia Treatment Center 2016--Nursing Services

In accordance with KRS 200.550, the Commission for Children with Special Health Care Needs is required to establish a Hemophilia Treatment Program within the Commission for detection, diagnosis and treatment of persons suffering from Hemophilia. The Division of Pediatric Hematology/Oncology Center on behalf of the University of Kentucky Hemophilia Treatment Center (UKHTC) has historically collaborated with the Commission in order to provide comprehensive hemophilia treatment services. This collaboration has been essential due to due to the complexity involved in maintaining such services, both financially and resource based, for which the Commission would experience difficulty. In addition, Dr. Jeffrey Moscow at the University of Kentucky Division of Pediatric Hematology/Oncology pharmacy management program has provided the outlet for obtaini ng Factor and managing its use. With the use of the pharmacy management program, the Commission has benefited by securing an outlet to supply our hemophilia patient's factor at a greatly reduced price on a statewide basis. This has eliminated the ex treme cost associated with establishing a 3408 Program to dispense Factor. Through supplementi ng the Division of Pediatric Hematology/Oncology Center, through the University of Kentucky Hemophilia Treatment Center (UKHTC), with costs associated with maintaining a Hemophilia Treatment Program and a 3408 Program, the Commission for Children with Special Hea lth Care Needs has been provided with the foundation necessary to meet statute, while also avoiding the cost associated with establishing its own Hemophilia Treatment Program